Wilms tumor (nephroblastoma) is the most common primary malignant renal tumor in children, accounting for approximately 95% of all pediatric kidney cancers. While the survival rate has improved dramatically—from 30% in the 1930s to over 90% today—the landscape of management is constantly evolving.